Hope and Disappointment: Unpacking the Latest Research on Lipoic Acid for Progressive Multiple Sclerosis
It's a frustrating reality: despite significant advancements, effective treatments for progressive multiple sclerosis (MS) remain elusive. A recent study, spearheaded by Oregon Health & Science University and the Portland VA Health Care System, has offered a glimmer of hope, but also a dose of reality regarding the use of lipoic acid, an over-the-counter supplement, in combating this debilitating disease.
This research, published in the journal Neurology, examined the effects of lipoic acid on individuals with progressive forms of MS. The study's lead author, Rebecca Spain, M.D., M.S.P.H., and her team sought to determine if this supplement could offer a therapeutic advantage.
The study involved 54 participants with primary progressive and secondary progressive MS. These individuals were given a daily dose of 1,200 milligrams of lipoic acid over a two-year period. The results were then compared to those of 61 participants who received a placebo. The primary goal was to assess the impact on walking speed, a key indicator of disease progression. Secondary outcomes included brain atrophy (measured by MRI), other clinical outcomes, and safety.
The Findings: A Mixed Bag
While the study didn't deliver the breakthrough researchers had hoped for, it did reveal some intriguing details. The results showed that lipoic acid might have a small beneficial effect in slowing the loss of gray matter in the brain. However, it didn't improve the primary clinical outcome, which was walking speed.
"It didn’t work clinically in progressive multiple sclerosis the way we hoped," Dr. Spain explained. "However, the slowing of brain atrophy that we saw in MRI images suggests that we may yet be on the right track, especially if we can find a better way to deliver the beneficial effects of an antioxidant like lipoic acid.”
Understanding the Science Behind MS
Multiple sclerosis is a complex autoimmune disease that affects the central nervous system. It damages myelin, the protective sheath around nerve fibers, disrupting the transmission of electrical signals. This damage can lead to a wide range of symptoms, including vision problems, muscle weakness, and cognitive difficulties. Worldwide, an estimated 2.8 million people have been diagnosed with MS.
Lipoic Acid: A Closer Look
Researchers hypothesized that lipoic acid, with its potential anti-inflammatory and antioxidant properties, could protect myelin and underlying nerves. But here's where it gets controversial: lipoic acid is lipophobic. This means it doesn't easily cross the blood-brain barrier, which might limit its effectiveness in the central nervous system.
The Path Forward: More Research Needed
The research team is now expanding their efforts through a broader research project based in the United Kingdom called Optimal Clinical Trials Platform for Multiple Sclerosis, known as Octopus. This initiative will test lipoic acid and metformin, another potential treatment, against a placebo in a much larger group of participants.
"In combination with this Octopus trial, we are going to learn more about whether lipoic acid is worth taking if you have progressive MS," Dr. Spain said. "I am cautiously optimistic."
Controversy & Comment Hooks:
What are your thoughts on this research? Do you think the potential benefits of slowing brain atrophy outweigh the lack of improvement in walking speed? Do you think the dosage of lipoic acid used in the study was appropriate? Share your opinions in the comments below!
This work was supported by the Department of Veterans Affairs, the National Multiple Sclerosis Society, and the Multiple Sclerosis Society of Canada.
